Researchers at the University of Gothenburg and Sahlgrenska University Hospital have conducted the first randomized clinical trial in the world to test cortisone eye drops to slow the progression of serious eye disease in extremely premature babies. The results suggest that the intervention can reduce the need for invasive treatment for Retinopathy of prematurity (ROP), a disease that causes blindness in 35,000 children worldwide each year.